Paper No. ____
`Filed: March 28, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.,
`LUPIN LTD., and LUPIN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
` SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00903 (Patent 8,129,431 B2)*
`
`
`
`
`
`
`
`JOINT REQUEST FOR ORAL HEARING
`
`
`
`
`
`
`
`
`
`
`
`
`*. IPR2015-01871 has been joined with this proceeding.
`
`

`
`The Board tentatively scheduled oral hearing for IPR2015-00902 and
`
`Case IPR2015-00903
`Patent No. 8,129,431
`
`
`IPR2015-00903, which involve some common parties and related patents, namely
`
`U.S. Patent No. 8,669,290 and U.S. Patent No. 8,129,431, for April 19, 2016.
`
`Paper 19, Scheduling Order, at 7. Pursuant to 37 C.F.R. § 42.70(a) and as directed
`
`by the Board’s email of March 21, 2016, attached hereto as Attachment A,
`
`Petitioner and Patent Owner (“the Parties”) request a consolidated oral hearing,
`
`two hours total, on the instituted grounds of unpatentability in each of the
`
`proceedings, including:
`
`• whether claims 1-30 of the ’290 patent are obvious over Ogawa and
`
`Sallmann;
`
`• whether claims 1-5, 7-14 and 18-19 of the ’431 are obvious over Ogawa
`
`and Sallmann; and
`
`• whether claims 6, 15-17 and 20-22 of the ’431 patent are obvious over
`
`Ogawa, Sallmann, and Fu.
`
`Patent Owner also requests oral hearing on any motions to exclude filed by either
`
`party. Petitioner, however, does not believe oral hearing on any motions to
`
`exclude is necessary, but will be prepared to address any issues should the Board
`
`so desire.
`
`
`
`The Parties request sixty minutes per side to address these issues. The
`
`Parties have agreed to the following sequential allocation of time periods during
`
`

`
`the argument: 45 minutes (Petitioner), sixty minutes (Patent Owner), and 15
`
`Case IPR2015-00903
`Patent No. 8,129,431
`
`
`minutes (Petitioner). In the event the Board allocates more or less than sixty
`
`minutes per side, the Parties have agreed to scale these time periods accordingly.
`
`Petitioner requests that ten spaces be reserved at the oral hearing to
`
`accommodate their counsel (InnoPharma Petitioner and Lupin Petitioner), and
`
`corporate representatives. Patent Owner requests that ten spaces be reserved at the
`
`oral hearing to accommodate their counsel and corporate representatives. This
`
`paper is being filed by counsel for Patent Owner with the approval of Petitioners.
`
`Dated: March 28, 2016
`
`Respectfully submitted,
`
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Registration No. 32,409
`
`Attorney for Patent Owner
`
`
`
`

`
`
`ATTACHMENT A
`ATTACHMENT A
`
`
`
`
`
`
`
`
`
`

`
`From:
`To:
`Cc:
`
`Subject:
`Date:
`
`Vignone, Maria on behalf of Trials
`Malik, Jitty; Trials
`Diner, Bryan; Hasford, Justin; EXT- bryan.skelton@alston.com; Abe, James; Janusz, Joe; dyellin@crowell.com;
`jlindsay@crowell.com; slentz@crowell.com; Ferrill, Elizabeth; Fujiwara, Chiaki; Lebeis, Jessica; EXT-
`deepro.mukerjee@alston.com; Goldberg, Joshua; Rapalino, Emily L. (ERapalino@goodwinprocter.com)
`RE: IPR2015-00902 and -00903 (Request for Sur-Reply)
`Monday, March 21, 2016 3:52:08 PM
`
`Counsel:  The Board will determine whether, under 37 C.F.R. § 42.23(b), Petitioner’s Reply briefs,
`and related evidence, are outside the scope of a proper reply and evidence, when the panel reviews
`the record and prepares any final written decision in connection with these proceedings. If there are
`improper arguments or evidence, or both, presented with the Reply briefs, the panel may exclude
`such argument and related evidence.  Patent Owner’s request to file a sur-reply in each proceeding
`to address allegedly new arguments presented in the Reply briefs is denied.
` 
`Further, to the extent that either party wishes to request an oral hearing (currently set, if requested,
`for April 19, 2016 (Due Date 7)), such request must be filed within five (5) business days of this
`email.
` 
`Thank you,
` 
`Maria Vignone
`Paralegal Operations Manager
`Patent Trial and Appeal Board
`703-756-1288
`
`   
`
`From: Malik, Jitty [mailto:Jitty.Malik@alston.com] 
`Sent: Monday, March 21, 2016 11:20 AM
`To: Trials <Trials@USPTO.GOV>
`Cc: Diner, Bryan <bryan.diner@finnegan.com>; Hasford, Justin <Justin.Hasford@finnegan.com>;
`Skelton, Bryan <Bryan.Skelton@alston.com>; Abe, James <James.Abe@alston.com>; Janusz, Joe
`<Joe.Janusz@alston.com>; dyellin@crowell.com; jlindsay@crowell.com; slentz@crowell.com; Ferrill,
`Elizabeth <Elizabeth.Ferrill@finnegan.com>; Fujiwara, Chiaki <Chiaki.Fujiwara@finnegan.com>;
`Lebeis, Jessica <Jessica.Lebeis@finnegan.com>; Mukerjee, Deepro <Deepro.Mukerjee@alston.com>;
`Goldberg, Joshua <Joshua.Goldberg@finnegan.com>; Rapalino, Emily L.
`(ERapalino@goodwinprocter.com) <ERapalino@goodwinprocter.com>
`Subject: RE: IPR2015-00902 and -00903 (Request for Sur-Reply)
` 
`Dear PTAB,
` 
`Petitioner does not agree with Patent Owner’s characterizations that the arguments were outside
`the scope of Patent’s Owner’s Response.  Rather Petitioner’s expert, Dr. Laskar (who was
`Petitioner’s original declarant when Petitioner filed its petition) was responding directly to certain
`arguments made by Patent Owner in its Response and by its experts.  That being said, Petitioner
`InnoPharma (along with joined Petitioner Lupin) are available for a conference call to discuss this
`
`

`
`matter tomorrow afternoon.
` 
`Regards,
` 
`Jitty  Malik
`Lead Counsel for Petitioner.
`
`  
`
`_____________________________________________
`JiTendra “JiTTy” Malik Ph.d. | ParTner | alSTon + Bird llP
`4721 Emperor Boulevard, Suite 400
`Durham, North Carolina 27703-8580 
`Direct: (919) 862-2210; Fax: (919) 862-2260
`jitty.malik@alston.com | www.alston.com
`Atlanta | Charlotte | Dallas | Research Triangle | New York | Los Angeles | Palo Alto | Washington, DC
`
`      
`
`From: Goldberg, Joshua [mailto:Joshua.Goldberg@finnegan.com] 
`Sent: Monday, March 21, 2016 11:07 AM
`To: trials@uspto.gov
`Cc: Diner, Bryan; Hasford, Justin; Malik, Jitty; Skelton, Bryan; Abe, James; Janusz, Joe;
`dyellin@crowell.com; jlindsay@crowell.com; slentz@crowell.com; Ferrill, Elizabeth; Fujiwara, Chiaki;
`Lebeis, Jessica
`Subject: IPR2015-00902 and -00903 (Request for Sur-Reply)
` 
`Dear PTAB,
` 
`Petitioner included new exhibits, including a new declaration, raising arguments outside the scope
`of the Petition and Patent’s Owner’s Response with each of its replies filed on March 18, 2016.  To
`protect Patent Owner’s rights, as recently recognized by the Federal Circuit in Dell v. Accelleron,
`Patent Owner requests a sur-reply in each proceeding to address the new arguments in the replies
`that are based on these exhibits.  Petitioner opposes this request.  Petitioner and Patent Owner are
`available for a conference call to discuss this matter tomorrow afternoon.
` 
`Best regards,
`Joshua L. Goldberg
`Reg. No. 59,369
`Backup Counsel for Patent Owner
` 
`Joshua L. Goldberg
`Attorney at Law
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`
`

`
`901 New York Avenue, NW, Washington, DC 20001-4413
`202.408.6092 | fax 202.408.4400 | joshua.goldberg@finnegan.com
`www.finnegan.com | Bio | LinkedIn | PTAB Guidebook
` 
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged,
`confidential, proprietary, or otherwise exempt from disclosure under applicable law. If you believe you have received this message in
`error, please advise the sender by return e-mail and delete it from your mailbox. Thank you.
`
` 
`
`NOTICE: This e-mail message and all attachments may contain legally privileged and
`confidential information intended solely for the use of the addressee. If you are not the
`intended recipient, you are hereby notified that you may not read, copy, distribute or
`otherwise use this message or its attachments. If you have received this message in error,
`please notify the sender by email and delete all copies of the message immediately.
`
`

`
`Case IPR2015-00903
`Patent No. 8,129,431
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing JOINT
`
`
`
`
`
`REQUEST FOR ORAL HEARING was served on March 28, 2016, via email
`
`directed to counsel of record for the Petitioner at the following:
`
`Jitendra Malik, Ph.D
`Jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Bryan.skelton@alston.com
`
`Lance Soderstrom
`Lance.soderstrom@alson.com
`
`Hitetada James Abe
`James.abe@alston.com
`
`Joseph M. Janusz
`Joe.janusz@alston.com
`
`Deborah Yellin
`dyellin@crowell.com
`
`Jonathan Lindsay
`jlindsay@crowell.com
`
`Shannon Lentz
`slentz@crowell.com
`
`/Bradley J. Moore/
`Bradley J. Moore
`Litigation Legal Assistant
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`Dated: March 28, 2016